Retreatment with Pegloticase after a Gap in Therapy in Patients with Gout: A Report of Four Cases

INTRODUCTION: Pegloticase, a potent uricolytic biologic enzyme, has been shown to be an effective therapeutic option in patients with uncontrolled gout. However, there are limited data on clinical response after a gap in therapy and retreatment with pegloticase. CASE SERIES: This report describes fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Morton, Allan H., Hosey, Tony, LaMoreaux, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251856/
https://www.ncbi.nlm.nih.gov/pubmed/29725991
http://dx.doi.org/10.1007/s40744-018-0111-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251856/
https://www.ncbi.nlm.nih.gov/pubmed/29725991
http://dx.doi.org/10.1007/s40744-018-0111-9

Ejemplares similares